Movement Disorders

Papers
(The H4-Index of Movement Disorders is 46. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
The FDA Has Ended Required Blood Monitoring for Clozapine Use—Will This Impact the Management of Parkinson's Disease Psychosis?321
Multimodal Imaging Investigation of the Dentato‐Thalamo‐Cortical Pathway in Friedreich's Ataxia229
Plasma Biomarkers and Positron Emission Tomography Tau Pathology in Progressive Supranuclear Palsy159
Treatment for Dyskinesia in Parkinson's Disease: A Network Meta‐analysis of Randomized Controlled Trials159
Investigation of Shared Genetic Risk Factors Between Parkinson's Disease and Cancers116
109
May Infographic107
Movement Disorders: Volume 40, Number 6, June 2025106
Movement Disorders: Volume 40, Number 2, February 2025105
Motor Cortex Disinhibition Correlates with Olfactory Dysfunction in Parkinson's Disease105
John Michael Walshe (April 24, 1920–October 14, 2022)99
Issue Information94
In Memoriam Mahlon R. DeLong (1938–2024)83
Stability of Mosaic Divergent Repeat Interruptions in X‐Linked Dystonia‐Parkinsonism82
Deep Brain Stimulation of the Globus Pallidus Internus and Externus in Multiple System Atrophy80
α‐Synuclein V15A Variant in Familial Parkinson's Disease Exhibits a Weaker Lipid‐Binding Property77
The Pattern and Stages of Atrophy in Spinocerebellar Ataxia Type 2: Volumetrics from ENIGMA‐Ataxia74
The Views of Patients with Isolated Rapid Eye Movement Sleep Behavior Disorder on Risk Disclosure73
Adaptive Deep Brain Stimulation: From Experimental Evidence Toward Practical Implementation69
The Emergence and Progression of Motor Dysfunction in Individuals at Risk of Parkinson's Disease66
A Double‐Blind, Randomized, Placebo‐Controlled Trial of Ursodeoxycholic Acid (UDCA) in Parkinson's Disease66
Substantia Nigra Elasticity Measurement Using Transcranial Shear Wave Elastography: A Potential Biomarker for Parkinson's Disease66
Bidirectional Transcription at the PPP2R2B Gene Locus in Spinocerebellar Ataxia Type 1265
Fixel‐Based Analysis Reveals Whole‐Brain White Matter Abnormalities in Cervical Dystonia65
Early Changes in Striatal Activity and Motor Kinematics in a Huntington's Disease Mouse Model65
The Hypoxia Response Pathway: A Potential Intervention Target in Parkinson's Disease?63
Annonaceae Consumption Worsens Disease Severity and Cognitive Deficits in Degenerative Parkinsonism63
Risk Factors for the Diagnosis of Progressive Supranuclear Palsy in the UK Biobank63
Assessing Intronic Variable Number Tandem Repeat ( VNTR) Expansions of the HSF1 62
Prevalence of NOTCH2NLC and FMR1 Repeat Expansions in Atypical Parkinsonism Compared to Asymptomatic Elderly Individuals60
A GJA1 Variant Triggers Earlier SPG4 Onset by Destabilizing Deubiquitinase 59
Safety, Tolerability, Pharmacokinetics, and Brain Target Occupancy of the OGA Inhibitor ASN90 in H55
Biallelic Variants in SLC27A3 Cause a Complex Form of Neurodegeneration with Brain Iron Accumulati54
Indirect Striatal Projection Neurons Drive a D2 Receptor‐Dependent Pathway to Dyskinesia and Dystonia53
Rapid Eye Movement Sleep Behavior Disorder with Clinical Dementia with Lewy Bodies Phenotype but Lacking Postmortem Central Nervous System Synuclein Pathology: Alternate Etiologies53
Bilateral Globus Pallidus Deep Brain Stimulation Improves Motor Function in ADCY5 ‐Related Disorde52
Patients with Allan‐Herndon‐Dudley Syndrome (MCT8 Deficiency) Display Symptoms of Parkinsonism in Childhood and Respond to Levodopa/Carbidopa Treatment51
Friedreich's Ataxia in Colombia: A Population‐Based Study of Incidence and Socioeconomic Determinants49
Brain–Computer Interface Improves Symptoms of Isolated Focal Laryngeal Dystonia: A Single‐Blind Study49
Research Priorities on the Role of α‐ Synuclein in Parkinson's Disease Pathogenesis49
Apolipoprotein E Polymorphism Is Associated with Age of Onset and Neuropathology in Colony Stimulating Factor 1 Receptor‐Related Disorder48
Navigating Visual Challenges: How Parkinson's Disease Alters Cognitive Priorities in Visual Search46
The Lows of High Reward: Choking Under Pressure46
Compound Heterozygous Structural Variants in Cases with Unsolved PRKN ‐Associated Parkinson's Dise46
Clinical Outcome Assessments for Functional Performance in Spastic Paresis: Systematic Review, Critique, and Recommendations46
In Vivo Investigation of Glucose Metabolism in Idiopathic and PRKN‐Related Parkinson's Disease46
0.18104696273804